Pharming Group N.V.

Pharming Group N.V.verified

PHARM.AS

Price:

$1.466

Market Cap:

$1.18B

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The com...[Read more]

Industry

Biotechnology

IPO Date

1999-06-16

Stock Exchange

AMS

Ticker

PHARM.AS

The Enterprise Value as of December 2025 (TTM) for Pharming Group N.V. (PHARM.AS) is 1.18B

According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.18B. This represents a change of 120.23% compared to the average of 535.05M of the last 4 quarters.

Pharming Group N.V. (PHARM.AS) Historical Enterprise Value (quarterly & annually)

How has PHARM.AS Enterprise Value performed in the past?

The mean historical Enterprise Value of Pharming Group N.V. over the last ten years is 739.28M. The current 1.18B Enterprise Value has changed 15.84% with respect to the historical average. Over the past ten years (40 quarters), PHARM.AS's Enterprise Value was at its highest in in the December 2019 quarter at 1.25B. The Enterprise Value was at its lowest in in the September 2025 quarter at -1448000.00.

Quarterly (TTM)
Annual

Average

739.28M

Median

741.90M

Minimum

125.74M

Maximum

1.30B

Pharming Group N.V. (PHARM.AS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pharming Group N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 427.24%

Maximum Annual Enterprise Value = 1.30B

Minimum Annual Increase = -37.72%

Minimum Annual Enterprise Value = 125.74M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024692.88M-33.60%
20231.04B5.98%
2022984.54M51.68%
2021649.11M-37.72%
20201.04B-20.04%
20191.30B113.57%
2018610.36M-22.83%
2017790.92M427.24%
2016150.01M19.31%
2015125.74M-17.02%

Pharming Group N.V. (PHARM.AS) Average Enterprise Value

How has PHARM.AS Enterprise Value performed in the past?

The current Enterprise Value of Pharming Group N.V. (PHARM.AS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

906.95M

5-year avg

882.45M

10-year avg

739.28M

Pharming Group N.V. (PHARM.AS) Enterprise Value vs. Peers

How is PHARM.AS’s Enterprise Value compared to its peers?

Pharming Group N.V.’s Enterprise Value is less than Galapagos N.V. (1.73B), less than Koninklijke BAM Groep nv (2.18B), less than Fugro N.V. (1.38B), less than PostNL N.V. (1.19B), less than AMG Critical Materials N.V. (1.61B),

CompanyEnterprise ValueMarket cap
1.73B$1.80B
2.18B$2.33B
1.38B$943.04M
1.19B$534.11M
1.61B$894.50M

Build a custom stock screener for Pharming Group N.V. (PHARM.AS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharming Group N.V. (PHARM.AS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pharming Group N.V.'s Enterprise Value?

What is the highest Enterprise Value for Pharming Group N.V. (PHARM.AS)?

What is the 3-year average Enterprise Value for Pharming Group N.V. (PHARM.AS)?

What is the 5-year average Enterprise Value for Pharming Group N.V. (PHARM.AS)?

How does the current Enterprise Value for Pharming Group N.V. (PHARM.AS) compare to its historical average?